169316 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids; General methods of protein analysis not limited to specific proteins or families of proteins Methods of protein analysis involving mass spectrometry
Quantitation of insulin-like growth factor-I and insulin-like growth factor-II with high-resolution mass spectrometry
#902METHODS FOR PEPTIDE MASS SPECTROMETRY FRAGMENTATION PREDICTION
#903METHODS FOR THE PREPARATION OF TRYPSIN-RESISTANT POLYPEPTIDES FOR MASS SPECTROMETRIC ANALYSIS
#904Cryptic metabolites and method for activating silent biosynthetic gene clusters in diverse microorganisms
#905Methods for detecting AAV
#906Acid-labile surfactants
#907Screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios
#908IMPROVED METHODS FOR IMMUNOAFFINITY ENRICHMENT AND MASS SPECTROMETRY
#909Methods for diagnosing an autistic spectrum disorder
#910AFFINITY CHROMATOGRAPHY-COUPLED NATIVE MASS SPECTROMETRY FOR ANTIBODY ANALYSIS
#911Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK
#912PepCon proteomics standards and methods of use
#913CONSTRAINED DE NOVO SEQUENCING OF NEO-EPITOPE PEPTIDES USING TANDEM MASS SPECTROMETRY
#914Compositions for and methods of diagnosing, prognosing, and treating diabetes
#915Multiplexed bead-based analytical assays
#916Bioanalytical analysis of site-specific antibody drug conjugates
#917C peptide detection by mass spectrometry
#918Method for improving result monoclonal antibody detection
#919Integrated sample processing system with multiple detection capability
#920Methods of detecting and treating pulmonary hypertension
#921APPARATUS AND METHOD FOR MULTIPLEXED PROTEIN QUANTIFICATION
#922Bioinformatics platform for high-throughput identification and quantification of O-glycopeptide
#923Palmitoyl Protein Biomarkers in Purified Extracellular Vesicles for Early Identification of Clinically Significant Prostate Cancer
#924Aptamer based affinity capture methods for the selective enrichment of human immunoglobulin Fc domains
#925ARRAY-BASED CYCLIC PEPTIDE LIBRARIES
#926Spectrometric analysis
#927Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#928ASSAYS FOR RECOMBINANT EXPRESSION SYSTEMS
#929Methods for quantifying drug concentration in a prodrug composition
#930Analytical method and apparatus using fingerprints on the basis of types in expression levels of express trace proteins and/or peptides contained in living tissue and/or biological fluid
#931Metabolic biomarker set for assessing ovarian cancer
#932RPLC-based peptide mapping chromatographic performance using metal chelators as mobile phase additives
#933Deconvolution of mass spectrometry data
#934Method of fragmenting and charge reducing biomolecules
#935Quantitative analysis of proteins
#936Microwave enhanced enzymatic reactor for proteomics by mass spectrometry
#937Peptide mapping method for sequence identification of insulin and insulin analogues
#938Operating a mass spectrometer utilizing mass spectral database search
#939Method and system for analyzing N-linked sugar chains of glycoprotein
#940COMPANION DIAGNOSTIC FOR HTRA1 RNA ANTAGONISTS
#941Method for determining the distinctive nutritional requirements of a patient
#942Tumor-specific polypeptide and use thereof
#943System for the analysis of complex mixtures of organic molecules with an enhanced degree of information extraction
#944ACID-MEDIATED ASSAY FOR ANALYZING LIGAND-DRUG CONJUGATES
#945Protein biomarker indicators of neurological injury and/or disease and methods of use thereof
#946Method for the Diagnosis of Hereditary Angioedema
#947METHOD FOR IDENTIFYING PROTEINS
#948DETECTION AND QUANTIFICATION OF RAS-RAF-MAPK PATHWAY PROTEINS
#949Systems and methods for performing a real-time assay of a sample
#950Dual mass spectrometry-cleavable crosslinking reagents for protein-protein interactions
#951DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS BASED ON AMINE CONTAINING METABOTYPES
#952Methods for quantitation of functional C1 esterase inhibitor (FC1-INH)
#953SRM methods in Alzheimer's disease and neurological disease assays
#954Isotyping immunoglobulins using accurate molecular mass
#955METHODS FOR QUANTITATING PROTEIN BIOMARKERS
#956Methods for detecting lacosamide by mass spectrometry
#957ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
#958Mass spectrometry assay for congenital adrenal hyperplasia
#959Methods and reagents to label bacteria and virus and identify their interacting proteins
#960Identification of host cell proteins
#961PD-1 related cancer therapy
#962Evaluation of complex mass spectrometry data from biological samples
#963METHODS FOR DETERMINING ISOMERIC AMINO ACID RESIDUES OF PROTEINS AND PEPTIDES
#964LAMELLAR BODY PURIFICATION FOR DIAGNOSIS AND TREATMENT OF A DISEASE OR DISORDER
#965Systems and methods for de novo peptide sequencing using deep learning and spectrum pairs
#966Spatially encoded biological assays
#967Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#968METHODS FOR MONITORING TUBERCULOSIS MEDICATION
#969Rapid identification and sequence analysis of intact proteins in complex mixtures
#970Selection biomarkers for patient stratification in bodily fluids and applying precision medicine through novel diagnostic biomarkers
#971System and method for characterizing protein dimerization
#972Solution-phase affinity selection of inhibitors from combinatorial peptide libraries
#973Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#974Prognosis and progression biomarkers for chronic kidney disease
#975Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry
#976Identification and monitoring of apoptosis inhibitor of macrophage
#977Preparing live microbial samples and microorganisms for subsequent mass spectrometric measurement and evaluation
#978Uses of isobaric tags in mass spectrometry
#979METHODS FOR DETECTION OF FOLATE RECEPTOR 1 IN A PATIENT SAMPLE
#980Quantitation of insulin by mass spectrometry of insulin A chain
#981Methods of use for low-bind polypropylene plates and vials
#982Methods of characterizing condensate-associated characteristics of compounds and uses thereof
#983Identification and monitoring of immunoglobulin J chains
#984Methods for sequentially preparing different test samples from a single dried blood sample
#985Collection probe and methods for the use thereof
#986Utilising fragmentation in analysis of lipids and other compound classes
#987Astrocyte traumatome and neurotrauma biomarkers
#988Protein Expression Analysis For Breast Cancer Prognosis And Treatment
#989Virus-like particle (VLP) based small molecule-protein interaction trap
#990IDENTIFICATION AND MONITORING OF ACID HYDROLYSIS PRODUCTS OF IMMUNOGLOBULIN HEAVY CHAINS
#991Quantifying MGMT Protein For Optimal Cancer Therapy
#992UCK2 Assay To Predict Cancer Therapy Response
#993ANTIBODY VALIDATION USING IP-MASS SPECTROMETRY
#994Mass spectrometry-based methods for the detection of circulating histones H3 and H2B in plasma from sepsis or septic shock (SS) patients
#995Global proteomic screening of random bead arrays using mass spectrometry imaging
#996Collision surface for improved ionisation
#997Methods for detecting cancers, and detecting reagent
#998Selenium Cancer Therapy
#999Method to obtain unbiased identification of interaction of test compounds with the proteome
#1000Native microfluidic CE-MS analysis of antibody charge heterogeneity
#1001Methods for resolving lipoproteins with mass spectrometry
#1002Method For Protein Kinase Activity Ranking
#1003Method and system for identifying membrane proteins on extracellular vesicles
#1004Copy protection for antibodies
#1005Interactive analysis of mass spectrometry data including peak selection and dynamic labeling
#1006SYSTEMS AND METHODS FOR PATIENT-SPECIFIC IDENTIFICATION OF NEOANTIGENS BY DE NOVO PEPTIDE SEQUENCING FOR PERSONALIZED IMMUNOTHERAPY
#1007Method of characterization of visible and/or sub-visible particles in biologics
#1008Protein A chromatography-electrospray ionization mass spectrometer
#1009Quantitation and identification of dimers in co-formulations
#1010Detection of membrane proteins
#1011IDENTIFICATION AND USE OF BIOLOGICAL PARAMETERS FOR DIAGNOSIS AND TREATMENT MONITORING
#1012Method and system for determining equilibrium dissociation constant of a reversible binding pair
#1013Global proteomic screening of random bead arrays using mass spectrometry imaging
#1014Online chromatography and electrospray ionization mass spectrometer
#1015Techniques of mass spectrometry for isotopomer analysis and related systems and methods
#1016Microbial classification of a biological sample by analysis of a mass spectrum
#1017MEASUREMENT OF PROTEIN MOLECULAR FLUX RATES BY QUANTIFYING ISOTOPOLOGUE ABUNDANCES IN IMMONIUM ION USING HIGH RESOLUTION MASS SPECTROMETRY
#1018Methods of detecting osteoarthritis and predicting progression thereof
#1019Methods for identifying free thiols in proteins
#1020Methods for characterizing disulfide bonds
#1021Multiplexed proteomics and predictive drug candidate assessment
#1022Compositions and processes for improved mass spectrometry analysis
#1023MULTIPLEXED PROTEIN ASSAY FOR THE DETECTION OF MITOCHONDRIAL PROTEIN SIGNATURES
#1024Quantitation of Free and Total N-Acetylcysteine Amide and Its Metabolite N-Acetylcysteine in Human Plasma Using Derivatization and Electrospray LC-MS/MS
#1025LC-MS configuration for purification and detection of analytes having a broad range of hydrophobicities
#1026BROAD SPECTRUM GPCR BINDING AGENTS
#1027Influenza potency assays
#1028COMPOSITIONS COMPRISING LIGANDS TO RHOB PROTEIN AND THE USES THEREOF
#1029Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer
#1030Process For The Characterization Of Glatiramer Acetate
#1031Sulfoxide-based reagent for mass spectrometry
#1032Devices, methods and kits for sample characterization
#1033System and method of analysis of a protein using liquid chromatography-mass spectrometry
#1034Rapid native single cell mass spectrometry
#1035Apparatus and methods for handling and spectrophotometry of small liquid samples
#1036Lysosomal acid lipase assay
#1037MARKER ANALYSIS FOR QUALITY CONTROL AND DISEASE DETECTION
#1038Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#1039Vitamin B2 detection by mass spectrometry
#1040Reagents for quantitative mass spectrometry
#1041Biomarkers for diagnosis of lung cancer
#1042Method for quantifying monoclonal antibody having antigen or anti-antibody bonded thereto
#1043QUANTIFYING SLFN11 PROTEIN FOR OPTIMAL CANCER THERAPY
#1044Methods to identify protein interaction
#1045Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders
#1046METHODS OF MEASURING UBIQUITIN-LIKE MODIFICATIONS
#1047Mass spectrometry assay method for detection and quantitation of organic acid metabolites
#1048Lysine monomethylated derivative and corresponding antibody and use thereof
#1049Methods, systems, and compositions for studying solvent accessibility and three-dimensional structure of biological molecules
#1050System and method of data-dependent acquisition by mass spectrometry
#1051Method for evaluating in vivo protein nutrition based on LC-MS-MS technique
#1052Blood sample analysis systems and methods
#1053Differentiation of lyme disease and southern tick-associated rash illness
#1054SRM/MRM Assay for the Tumor Necrosis Factor Receptor Superfamily Member 8 (CD30) Protein
#1055IDENTIFICATION OF IMMUNOGENIC MUTANT PEPTIDES USING GENOMIC, TRANSCRIPTOMIC AND PROTEOMIC INFORMATION
#1056METHOD FOR DETECTION OF LUNG CANCER
#1057BIOMARKER FOR DETECTING COLORECTAL CANCER
#1058Method for identifying microorganisms by mass spectrometry and score normalization
#1059Apparatus and method for glycopeptide analysis
#1060Methods for characterizing compositions comprising peanut antigens
#1061Method and kit for simultaneous detection of multi target molecules using magnetic bead-aptamer conjugate
#1062Methods for detecting lacosamide by mass spectrometry
#1063Method for identifying microorganisms by mass spectrometry
#1064Tandem identification engine
#1065METHODS OF PROTEIN INTERACTION ANALYSIS
#1066Method for preparing analytical sample, analysis method, and kit for preparing analytical sample
#1067BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS USING THE SAME
#1068Method for detecting multispecific antibody light chain mispairing
#1069Method for the absolute quantification of naturally processed hla-restricted cancer peptides
#1070System and method for determining glycan topology using tandem mass spectra
#1071QUANTIFICATION OF TRANSTHYRETIN AND ITS ISOFORMS
#1072Tissue-derived extracellular vesicles and their use as diagnostics
#1073CANCER SCREENING PROCESSOR, CANCER SCREENING SYSTEM, AND CANCER SCREENING PROCESSING METHOD
#1074Methods and systems for diagnosing diseases
#1075Compositions and methods of diagnosing pancreatic cancer
#1076Methods and devices for evaluating the contents of materials
#1077INLET INSTRUMENTATION FOR ION ANALYSER COUPLED TO RAPID EVAPORATIVE IONISATION MASS SPECTROMETRY ("REIMS") DEVICE
#1078Analyzing High Dimensional Data Based on Hypothesis Testing for Assessing the Similarity between Complex Organic Molecules Using Mass Spectrometry
#1079Mapping protein binding sites and conformational epitopes using cysteine labelling and surface display library
#1080Photoreactive ligands and uses thereof
#1081Liquid trap or separator for electrosurgical applications
#1082Mass spectrometry assay for congenital adrenal hyperplasia
#1083Methods for assessing binding affinity of an antibody variant to the neonatal Fc receptor
#1084Cleavable probes for isotope targeted glycoproteomics and methods of using the same
#1085SYSTEMS AND METHODS FOR METABOLOME ANALYSIS
#1086Method for simultaneous quantification of ALXN1210 and eculizumab in human serum or urine
#1087Detection and Quantitation Method for Proteomics of Post-Translational Modifications
#1088COMPREHENSIVE AND QUANTITATIVE LIPID AND TOCOPHEROL ANALYSIS
#1089Immune Profiling Of Tumor Tissue
#1090Isolation and characterization of the nuclear proteome
#1091Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles
#1092METHODS TO ASSESS BINDING AGENT SPECIFICITY
#1093Detection and quantification of glycosylated peptides
#1094Microarray compositions and methods of their use
#1095Method for Simultaneous Quantification of Monoclonal Antibodies
#1096Isotyping immunoglobulins using accurate molecular mass
#1097Dual mass spectrometry-cleavable crosslinking reagents for protein-protein interactions
#1098Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1099Methods and systems for selective quantitation and detection of allergens including Gly m 7
#1100Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer
#1101Cyclin G1 inhibitors and related methods of treating cancer
#1102Sample preparation for proteomic investigations
#1103Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1104Rapid evaporative ionisation mass spectrometry (“REIMS”) and desorption electrospray ionisation mass spectrometry (“DESI-MS”) analysis of swabs and biopsy samples
#1105Pathogenic biomarkers and serum extracellular vesicular biomarkers associated with vascular malformation of endothelial cells, and uses thereof
#1106Methods and systems for LC-MS/MS proteomic genotyping
#1107HIGHLY MULTIPLEXED AND MASS SPECTROMETRY BASED METHODS TO MEASURING 72 HUMAN PROTEINS
#1108Simplified Biosample Processing for LC-MS/MS
#1109LOW ENERGY CLEAVABLE MASS TAG FOR QUANTITATIVE PROTEOMICS
#1110Identification, quantitation and analysis of unique biomarkers in sweat
#1111High Sensitivity Measurement of Parathyroid Hormone Related Peptide Using LC-MS/MS and Associated Method
#1112AUTOMATED DRUG ASSAYS
#1113Ligand identification by co-fractionation
#1114LC/MS/MS analysis for meat speciation in raw and processed meat product
#1115Method for determining origin of amino acid
#1116METHODS OF ANALYZING PLURALITIES OF CELLS AND DETECTING PROTEIN SEQUENCE VARIANTS IN BIOLOGICAL PRODUCT MANUFACTURING
#1117Laser ablation cell
#1118Improved Methods Of Treating Lung Cancer Using Multiplex Proteomic Analysis
#1119Virus-like particle (VLP) based small molecule-protein interaction trap
#1120TRANSLOCATION OF A POLYMER THROUGH A NANOPORE
#1121HIGH THROUGHPUT ANTIBODY VARIANT SCREENING METHOD
#1122Mass spectrometry assay method for detection and quantitation of kidney function metabolites
#1123Reagents and methods for analysis of proteins and metabolites targeted by covalent probes
#1124SYSTEMS AND METHODS FOR QUANTIFYING AND MODIFYING PROTEIN VISCOSITY
#1125METHOD TO DETERMINE BRAF MUTATIONS AND WILD TYPE BRAF PROTEIN BY MASS SPECTROMETRY
#1126ION BEAM SCANNING OF BIOLOGICAL SAMPLES
#1127Methods for diagnosis, differentiation and monitoring using urine proteins as markers in IgA nephropathy
#1128Method for diagnosing the sulphur nutrition state of a plant
#1129SINGLE CELL ANALYSIS USING SECONDARY ION MASS SPECTROMETRY
#1130Protein composition and methods for analysing microbiota
#1131Antigen-driven detection and treatment of coccidioidomycosis
#1132Method to analyze compounds in biological samples
#1133Thyroglobulin quantitation by mass spectrometry
#1134Method of early diagnosis of immune-mediated inflammatory disease
#1135Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration
#1136Techniques for high throughput targeted proteomic analysis and related systems and methods
#1137PROFILING EXTRACELLULAR VESICLES
#1138FORMALIN-FIXED ISOTOPE-LABELED REFERENCE STANDARDS AND METHODS FOR FABRICATION AND USE THEREOF
#1139Methods for quantitation of insulin levels by mass spectrometry
#1140Solution-phase affinity selection of inhibitors from combinatorial peptide libraries
#1141Quantifying phosphatidylethanol from blood samples
#1142Solid phase extraction, derivatization with crown ethers, and mass spectrometry, methods, reagents and kits
#1143Systems and methods for identifying HLA-associated tumor peptides
#1144URINE METABOLITE MARKER FOR CHILDHOOD CANCER
#1145Method for rapid and direct identification of microbial pathogen from positive culture sterile body fluids using mass spectrometry
#1146Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and Kawasaki disease
#1147Method for identifying a reagent during a process in an analysis system
#1148Mass spectrometry compatible salt formation for ionic liquid sample preparation
#1149Multidimensional chromatography method for analysis of antibody-drug conjugates
#1150Mass spectrometric determination of testosterone in multiplexed patient samples
#1151C peptide detection by mass spectrometry
#1152Mass spectrometry based bioinformatics platform for high-throughput identification of glycation proteins and advanced glycation end-products
#1153SRM/MRM Assays for Profiling Tumor Tissue
#1154Protein screening and detection method
#1155Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1156BIOLOGICAL SAMPLE COLLECTION METHOD AND BIOLOGICAL SAMPLE COLLECTION TOOL
#1157Identifying new therapeutic agents
#1158Method for preparing sample and analysis method
#1159Extraction system and method for extracting microorganisms contained in a sample
#1160Source-detector synchronization in multiplexed secondary ion mass spectrometry
#1161SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein
#1162Proteomic biomarkers of sepsis in elderly patients
#1163Method for evaluating data from mass spectrometry, mass spectrometry method, and MALDI-TOF mass spectrometer
#1164Linkers for protein interaction profiling and methods of making and using the same
#1165Monoisotopic mass determination of macromolecules via mass spectrometry
#1166Materials and methods for screening topoisomers
#1167Immobilized analytes
#1168Serologic assay of liver fibrosis
#1169Kisspeptin-54 detection by tandem mass spectrometry
#1170System and method for characterizing protein dimerization
#1171COMPOSITIONS AND METHODS FOR DETECTION OF BETA N METHYLAMINO L ALANINE IN CU ZN SUPEROXIDE DISMUTASE 1
#1172Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1173Methods for the quantitation of polypeptides
#1174ENTROPY OF IMMUNE HEALTH
#1175Dual-column LC-MS system and methods of use thereof
#1176SYSTEM AND METHOD FOR CHARACTERIZING DRUG PRODUCT IMPURITIES
#1177Detection of Exon 14 Deletion in the Met Protein
#1178Mass-spectrometer systems and methods
#1179METHOD FOR DETECTING CROSSLINKED PEPTIDES VIA REPRODUCIBLE FRAGMENTATION IN A MASS SPECTROMETER
#1180Pregnancy clock proteins for predicting due date and time to birth
#1181METHODS OF DETECTING HYPOXIA-ASSOCIATE PEPTIDES
#1182METHODS AND COMPOSITIONS FOR DETECTING PANCREATIC CANCER
#1183Ion beam focus adjustment
#1184Methods and systems for determining the biological age of samples
#1185Method of generating an inclusion list for targeted mass spectrometric analysis
#1186Method for diagnosing genitourinary cancers
#1187Systems and methods for pesticide detection using mass spectroscopy
#1188Carbonyl containing compound high-throughput quantitative analysis using isobaric multiplex reagents
#1189Personalized healthcare P4 cardiac health and wellness monitoring system and method utilizing TMAO and troponin
#1190Mass spectrometry technique for single cell proteomics
#1191Methods of enhancing MS detection of tagged glycans
#1192Personalized healthcare P4 drug monitoring system and method
#1193Predicting optimal chemotherapy for CRC
#1194Mass spectrometric methods and kits to identify a microorganism
#1195Microbial identification and quantitation using MS cleavable tags
#1196DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS
#1197Chemoproteomic profiling of protein electrophilic and oxidative post-translational modifications
#1198Methods of identifying novel proteins and antigens in cancer cells
#1199Identification and monitoring of cleaved immunoglobulins by molecular mass
#1200Method and device for analyzing protein or peptide